Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1-Biosimilar and Originator Infliximab in the Hospital Setting.

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1-Biosimilar and Originator Infliximab in the Hospital Setting. — المؤلف: Moorkens, Evelien — BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20191118

المؤلف
Moorkens, Evelien
النشر
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20191118
الوصف
285-297 p.
الموضوعات
Antibodies, Monoclonal؛ Biosimilar Pharmaceuticals؛ Costs and Cost Analysis؛ Humans؛ Infliximab؛ Sweden